Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.85 USD | -0.95% |
|
-3.65% | +86.16% |
06-24 | Harrow, Inc.(NasdaqGM:HROW) added to S&P Pharmaceuticals Select Industry Index | CI |
06-21 | Craig-Hallum Adjusts Price Target on Harrow Health to $30 From $26, Buy Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+86.16% | 738M | |
+55.55% | 816B | |
+39.65% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.30% | 238B | |
+0.82% | 222B | |
+13.48% | 218B | |
+7.87% | 167B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours